Piramal Pharma Limited

216.25

-3.62 (-1.65%) tick

NSE

Buy Sell

NSE BSE

Last updated on 25 Apr 2025 03:34 PM

Open Demat account

Returns

-1.87%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

29146.57

Earning Per Share

2.96

Dividend Yield

0.09%

P/E Ratio

43.55

P/B Ratio

4.15

Debt to Equity

0.24

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries. It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India. In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.

Similar Companies

Laurus Labs

623.1 -22.40 (-0.03%) tick

1Yr Returns

+51.56%

Suven Pharmaceuticals

1145 -59.80 (-0.05%) tick

1Yr Returns

+86.27%

J.B.Chemicals & Pharma

1573.7 -35.40 (-0.02%) tick

1Yr Returns

-13.61%

Wockhardt

1389.9 -75.30 (-0.05%) tick

1Yr Returns

+156.75%

Emcure pharmaceuticals

1029.7 -43.50 (-0.04%) tick

1Yr Returns

-21.03%